Tsfg, LLC Dexcom Inc Transaction History

Tsfg, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$112.47 - $130.98 $2,699 - $3,143	24 New	24 $3,000
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $2,446 - $3,385	-26 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $15,454 - $19,375	-119 Reduced 82.07%	26 $14,000
Q3 2021 Oct 12, 2021	BUY	$106.71 - $143.18 $746 - $1,002	7 Added 5.07%	145 $79,000
Q2 2021 Jul 19, 2021	BUY	$80.99 - $107.93 $11,176 - $14,894	138 New	138 $59,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.